Related Experiment Video
Updated: Jun 26, 2026

A Simple Pit Assay Protocol to Visualize and Quantify Osteoclastic Resorption In Vitro
Published on: June 16, 2022
Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic
Robert Nason1, Jae Y Jung, Richard A Chole
1Department of Otolaryngology/Head and Neck Surgery, Washington University School of Medicine, St. Louis, MO, USA.
Abstract:
Osteoclasts are the only cells capable of carrying out bone resorption and therefore are responsible for the osteolysis seen in infectious diseases such as chronic otitis media and infected cholesteatoma. Pseudomonas aeruginosa is the most common organism isolated from these infectious middle ear diseases. In this study, we examined the mechanisms by which P. aeruginosa lipopolysaccharide (LPS) stimulates osteoclastogenesis directly from mononuclear osteoclast precursor cells. Osteoclast precursors demonstrated robust, bone-resorbing osteoclast formation when stimulated by P. aeruginosa LPS only if previously primed with permissive, sub-osteoclastogenic doses of receptor activator of NF-kappaB ligand (RANKL), suggesting that LPS is osteoclastogenic only during a specific developmental window. Numerous LPS-elicited cytokines were found to be released by osteoclast precursors undergoing P. aeruginosa LPS-mediated osteoclast formation. Two lines of evidence suggest that several cytokines promote Oc formation in an autocrine/paracrine manner. First, inhibition of several cytokine pathways including TNF-alpha, IL-1, and IL-6 block the osteoclastogenesis induced by LPS. Secondly, increased expression of the receptors for TNF-alpha and IL-1 was demonstrated by real-time quantitative polymerase chain reaction. Such a mechanism has not previously been established and demonstrates the ability of osteoclast precursors to autonomously facilitate bone destruction.
Insights
Pseudomonas aeruginosa lipopolysaccharide (LPS) stimulates bone-resorbing osteoclast formation in precursor cells, but only when primed with RANKL. This process involves autocrine/paracrine cytokine signaling, highlighting a novel mechanism for bone destruction in infections.
Area of Science:
- Immunology
- Cell Biology
- Pathology
Background:
- Osteoclasts mediate bone resorption and osteolysis in infectious diseases.
- Pseudomonas aeruginosa is frequently isolated from infectious middle ear diseases.
Purpose of the Study:
- To investigate how P. aeruginosa lipopolysaccharide (LPS) directly stimulates osteoclastogenesis from mononuclear osteoclast precursor cells.
- To elucidate the role of cytokines in LPS-induced osteoclast formation.
Main Methods:
- Stimulation of osteoclast precursors with P. aeruginosa LPS and receptor activator of NF-kappaB ligand (RANKL).
- Analysis of cytokine release and receptor expression using real-time quantitative polymerase chain reaction.
- Inhibition of cytokine pathways (TNF-alpha, IL-1, IL-6) to assess their role in osteoclastogenesis.
Main Results:
- P. aeruginosa LPS induced osteoclast formation only in RANKL-primed osteoclast precursors.
- Osteoclast precursors released multiple cytokines upon LPS stimulation.
- Inhibition of TNF-alpha, IL-1, and IL-6 pathways blocked LPS-induced osteoclastogenesis.
- Increased expression of TNF-alpha and IL-1 receptors was observed.
Conclusions:
- P. aeruginosa LPS can directly stimulate osteoclastogenesis from precursor cells, contingent on RANKL priming.
- Cytokines, including TNF-alpha, IL-1, and IL-6, play a crucial autocrine/paracrine role in this process.
- Osteoclast precursors possess the capacity to autonomously drive bone destruction via cytokine signaling in response to P. aeruginosa LPS.
Related Concept Videos
Osteoclasts in Bone Remodeling
Bone Remodeling
Formation of Lipopolysaccharides
